Biomedical subjects

Jennifer Altamura Namazy

Publications and source records attributed to Jennifer Altamura Namazy.

5 recordsLinked to original sources

PubMed2006

Current guidelines for the management of asthma during pregnancy.

Over the past few years, much has been learned that is relevant to the management of asthma in pregnancy. Although the studies that were reviewed here in provide more insight into the mechanisms that are involved and the treatment of asthma during pregnancy, there are more questions to be answered. It is hoped that the updated guidelines, which address the safety of contemporary asthma medications during pregnancy, will be a helpful resource in the treatment of our pregnant asthmatic patients.

Adrenal Cortex Hormones↗

PubMed2005

Treatment of asthma during pregnancy and perinatal outcomes.

PURPOSE OF REVIEW: Asthma is the most common, potentially serious medical problem to complicate pregnancy. Women with asthma have been shown to be at increased risk of complications during pregnancy. Managing asthma during pregnancy is unique because the effect of both the illness and the treatment on the developing fetus as well as the patient must be considered. This review summarizes the recent studies addressing the effects of asthma or asthma medications on perinatal outcomes, including the 2004 Asthma and Pregnancy Working Group of the National Asthma Education and Prevention Program. RECENT FINDINGS: This review summarizes the recent studies addressing the effect of asthma or asthma medications on perinatal outcomes. SUMMARY: The prevalence of asthma in pregnant women appears to be increasing. Recent evidence supports that pregnant women with moderate to severe asthma may have an increased risk of adverse perinatal outcomes. The goal of asthma management during pregnancy is to optimize maternal and fetal health.

Administration, Inhalation↗

PubMed2005

Pregnancy and asthma: recent developments.

PURPOSE OF REVIEW: Asthma is the most common potentially serious medical problem to complicate pregnancy. Asthmatic women have been shown to be at an increased risk of complications during pregnancy. Managing asthma during pregnancy is unique because the effects of both the illness and the treatment on the developing fetus and the patient must be considered. RECENT FINDINGS: This review summarizes the recent studies addressing the interrelationships between asthma and pregnancy and general aspects of pharmacologic therapy of gestational asthma. SUMMARY: The prevalence of asthma in pregnant women appears to be increasing. Recent evidence supports that pregnant asthmatic women with moderate to severe asthma may have an increased risk of adverse perinatal outcomes. The goal of asthma management during pregnancy is to optimize maternal and fetal health.

Administration, Inhalation↗

PubMed2004

Update in the treatment of asthma during pregnancy.

Asthma is the most common potentially serious medical problem to complicate pregnancy. Recent reports suggest that 7 of every 100 pregnant women suffer from asthma during pregnancy. Asthmatic women have been shown to be at an increased risk of complications during pregnancy. This may be secondary to inadequately controlled asthma or perhaps the result of the effects of certain asthma medications taken during pregnancy. The choice to use a specific medication during pregnancy is based on available human and animal data. Much of the information currently available regarding the safety of various asthma medications during pregnancy comes from several large cohort studies. This article reviews the specific aspects of pharmacological therapy during pregnancy as provided in the recommendations of the joint ad hoc committee of the American College of Allergy Asthma and Immunology and the American College of Obstetricians and Gynecologists. This article presents practical strategies for the management of asthma in our pregnant patients.

Adrenergic beta-Agonists↗

PubMed2002

Sensitivity to nonsteroidal anti-inflammatory drugs.

BACKGROUND: Aspirin can provoke reactions ranging from respiratory to cutaneous in susceptible individuals. There has been particular attention looking at the role of cyclo-oxygenase enzymes 1 and 2 and their role in aspirin-exacerbated respiratory disease. OBJECTIVE: Patients who present with a spectrum of allergic and pseudoallergic reactions to aspirin pose a special challenge for the physician. This article discusses proposed classification system, clinical manifestations, pathogenesis of disease, and current treatment options of aspirin-related disease. DATA SOURCES: Relevant articles in the medical literature were derived from searching the MEDLINE database with key terms aspirin-sensitive asthma, cyclo-oxygenase enzymes 1 and 2. Sources also include review articles, randomized control trials, and standard textbooks of allergy and immunology. RESULTS: Aspirin-exacerbated respiratory disease remains a complex, heterogenous disease with varied clinical presentations. There have been many advances in trying to elucidate the pathogenesis of this disease. The classification system presented will provide greater ease when reading the literature and communicating with one another. Oral aspirin challenge remains the diagnostic test of choice for both respiratory and cutaneous reactions. Aspirin desensitization is an option for those with refractory respiratory disease or who require aspirin for other medical conditions. CONCLUSIONS: This review discusses the challenges in classification, diagnosis, and treatment of those patients with a sensitivity to aspirin. Special attention is made to the possible mechanisms mediating disease progression and how specific therapies, such as leukotriene modifiers, may be helpful.

Acetaminophen↗